TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.

Peter Hillmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.